Proportional Hazards Models
"Proportional Hazards Models" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Statistical models used in survival analysis that assert that the effect of the study factors on the hazard rate in the study population is multiplicative and does not change over time.
Descriptor ID |
D016016
|
MeSH Number(s) |
E05.318.740.500.700 E05.318.740.600.700 E05.318.740.750.725 E05.318.740.998.825 E05.599.835.900 N05.715.360.750.530.650 N05.715.360.750.625.650 N05.715.360.750.695.650 N05.715.360.750.795.825 N06.850.520.830.500.700 N06.850.520.830.600.700 N06.850.520.830.750.725
|
Concept/Terms |
Proportional Hazards Models- Proportional Hazards Models
- Proportional Hazard Models
- Hazard Model, Proportional
- Hazard Models, Proportional
- Model, Proportional Hazard
- Models, Proportional Hazard
- Proportional Hazard Model
- Models, Proportional Hazards
- Hazards Model, Proportional
- Hazards Models, Proportional
- Model, Proportional Hazards
- Proportional Hazards Model
Hazards Models- Hazards Models
- Hazards Model
- Model, Hazards
- Models, Hazards
- Hazard Models
- Hazard Model
- Model, Hazard
- Models, Hazard
|
Below are MeSH descriptors whose meaning is more general than "Proportional Hazards Models".
Below are MeSH descriptors whose meaning is more specific than "Proportional Hazards Models".
This graph shows the total number of publications written about "Proportional Hazards Models" by people in this website by year, and whether "Proportional Hazards Models" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 0 | 4 | 4 |
1996 | 0 | 5 | 5 |
1997 | 0 | 1 | 1 |
1998 | 0 | 8 | 8 |
1999 | 0 | 3 | 3 |
2000 | 0 | 7 | 7 |
2001 | 0 | 14 | 14 |
2002 | 0 | 13 | 13 |
2003 | 0 | 21 | 21 |
2004 | 0 | 23 | 23 |
2005 | 0 | 20 | 20 |
2006 | 0 | 25 | 25 |
2007 | 0 | 29 | 29 |
2008 | 0 | 34 | 34 |
2009 | 0 | 32 | 32 |
2010 | 0 | 38 | 38 |
2011 | 1 | 48 | 49 |
2012 | 1 | 40 | 41 |
2013 | 0 | 58 | 58 |
2014 | 0 | 65 | 65 |
2015 | 0 | 69 | 69 |
2016 | 2 | 77 | 79 |
2017 | 0 | 79 | 79 |
2018 | 0 | 49 | 49 |
2019 | 0 | 54 | 54 |
2020 | 0 | 29 | 29 |
2021 | 0 | 20 | 20 |
2022 | 0 | 12 | 12 |
2023 | 0 | 8 | 8 |
2024 | 0 | 16 | 16 |
2025 | 0 | 5 | 5 |
To return to the timeline,
click here.
Below are the most recent publications written about "Proportional Hazards Models" by people in Profiles.
-
Dietary Intake of Protein by Food Source and Incident Hypertension Among Diverse US Adults: The MESA Study. J Am Heart Assoc. 2025 May 20; 14(10):e037813.
-
Association of High-Sensitivity Troponins in Metabolic Dysfunction-Associated Steatotic Liver Disease With All-Cause and Cause-Specific Mortality. Aliment Pharmacol Ther. 2025 Jun; 61(11):1785-1793.
-
Improving Individualized Rhabdomyosarcoma Prognosis Predictions Using Somatic Molecular Biomarkers. JCO Precis Oncol. 2025 Feb; 9:e2400556.
-
Study of the Association Between Menarche and Disease Course in Pediatric Multiple Sclerosis. Neurology. 2025 Feb 25; 104(4):e210213.
-
Risk of carcinomas among children and adolescents with birth defects. Cancer Epidemiol. 2025 Apr; 95:102748.
-
Melanoma Among Adult Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study. J Clin Oncol. 2025 Apr; 43(10):1219-1228.
-
Defining the Optimal Radiation-induced Lymphopenia Metric to Discern Its Survival Impact in Esophageal Cancer. Int J Radiat Oncol Biol Phys. 2025 May 01; 122(1):31-42.
-
Adjuvant Dose-Dense Chemotherapy in Hormone Receptor-Positive Breast Cancer. J Clin Oncol. 2025 Apr; 43(10):1229-1239.
-
Protein Consumption and Risk of CVD Among U.S. Adults: The Multi-Ethnic Study of Atherosclerosis (MESA). Nutrients. 2024 Nov 02; 16(21).
-
Outcomes of patients treated with chemotherapy for breast cancer during pregnancy compared with nonpregnant breast cancer patients treated with systemic therapy. Cancer. 2025 Jan 01; 131(1):e35619.